Use Cases

Discover how SciBite’s powerful solutions are supporting scientists and researchers.

Use Cases Overview

Gartner report

Gartner® How to calculate business value and cost for generative AI use cases

Access report

Knowledge Hub

Explore expert insights, articles, and thought leadership on scientific data challenges.

Knowledge Hub

Resources

Discover our whitepapers, spec sheets, and webinars for in-depth product knowledge.

Resources

Events

Join us at upcoming events and webinars to learn more about SciBite solutions.

Events

News

Stay informed with the latest SciBite updates, announcements, and industry news.

News

About SciBite

Explore SciBite’s full suite of solutions to unlock the potential of your data.

Discover more about us

Our Partners

We build powerful partnerships with world-leading organizations.

Our Partners

Enabling a modern, efficient approach to pharmacovigilance [Use Case]

Regulatory bodies expect pharmaceutical companies to maintain an up-to-date awareness of the safety implications of not only their own drugs but also those from the same drug class and with the same target that are marketed by competitors. Comprehensive, systematic monitoring is required in order to detect, validate and act upon new adverse events as early as possible.

This places significant demands on Pharmacovigilance teams, who are challenged to maintain safety and compliance amid increasingly stringent, globally diverse regulations. The legacy approach, involving manually scanning biomedical sources, is prohibitively time consuming, has a high risk of missing safety signals and is no longer a viable option.

SciBite provides a resource-effective solution to the challenges faced by Pharmacovigilance teams by unlocking the potential of unstructured biomedical content. With SciBite, pharmaceutical companies can monitor a wide range of heterogeneous and cross-disciplinary sources and reach timely, well-informed decisions, resulting in safer treatments for patients.

To learn more, download the full use case.

Share this article
Relevant resources, events and news